Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Struthers

European heart journal

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
European Heart Journal|November 1, 1996
Diastolic dysfunction and ANP/BNP levelsA D Struthers
European Heart Journal|July 10, 1999
Further defining the role for natriuretic peptide levels in clinical practiceA D Struthers
European Heart Journal|December 24, 1997
Rationalizing the heart failure trials: from theory to practiceA D Struthers
European Heart Journal|December 1, 1995
Aldosterone escape during ACE inhibitor therapy in chronic heart failureA D Struthers
European Heart Journal|September 17, 1999
How to use natriuretic peptide levels for diagnosis and prognosisA D Struthers
European Heart Journal|September 7, 2000
N-terminal proBNP--the most cost effective way to identify post myocardial infarction left ventriular dysfunction?A D Struthers
European Heart Journal|February 3, 1998
Can drug effects on mortality in heart failure be predicted by any surrogate measure?K M Yee, A D Struthers
European Heart Journal|September 1, 1992
Comparison of three methods of glomerular filtration rate measurement with and without captopril pretreatment in groups of patients with left ventricular dysfunctionJ G Motwani, M K Fenwick, A D Struthers
European Heart Journal|February 1, 1994
Comparison of two methods of determining renal perfusion with and without captopril pretreatment in groups of patients with left ventricular dysfunctionJ G Motwani, M K Fenwick, A D Struthers
European Heart Journal|November 1, 1992
Practical issues when initiating captopril therapy in chronic heart failure. What is the appropriate dose and how long should patients be observed?J S McLay, J McMurray, A Bridges, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Heart Journal|November 1, 1996
Diastolic dysfunction and ANP/BNP levelsA D Struthers
European Heart Journal|July 10, 1999
Further defining the role for natriuretic peptide levels in clinical practiceA D Struthers
European Heart Journal|December 24, 1997
Rationalizing the heart failure trials: from theory to practiceA D Struthers
European Heart Journal|December 1, 1995
Aldosterone escape during ACE inhibitor therapy in chronic heart failureA D Struthers
European Heart Journal|September 17, 1999
How to use natriuretic peptide levels for diagnosis and prognosisA D Struthers
European Heart Journal|September 7, 2000
N-terminal proBNP--the most cost effective way to identify post myocardial infarction left ventriular dysfunction?A D Struthers
European Heart Journal|February 3, 1998
Can drug effects on mortality in heart failure be predicted by any surrogate measure?K M Yee, A D Struthers
European Heart Journal|September 1, 1992
Comparison of three methods of glomerular filtration rate measurement with and without captopril pretreatment in groups of patients with left ventricular dysfunctionJ G Motwani, M K Fenwick, A D Struthers
European Heart Journal|February 1, 1994
Comparison of two methods of determining renal perfusion with and without captopril pretreatment in groups of patients with left ventricular dysfunctionJ G Motwani, M K Fenwick, A D Struthers
European Heart Journal|November 1, 1992
Practical issues when initiating captopril therapy in chronic heart failure. What is the appropriate dose and how long should patients be observed?J S McLay, J McMurray, A Bridges, et al.
Pageof 2